Skip to main content

Table 13 Association of sub-clinical cardiotoxicity (EF changes ≥ 10%) with the NT-pro BNP changes six months after the completion of anthracycline chemotherapy

From: Electrocardiographic and biochemical analysis of anthracycline induced cardiotoxicity in breast cancer patients from Southern Sri Lanka

 

NT-pro BNP ≤ 125 pg/mL

NT-pro BNP > 125 pg/mL

EF difference (EF3-EF0) < 10%

80 (60.6%)

52 (39.4%)

EF difference (EF3-EF0) ≥ 10%

25 (39.1%)

39 (60.9%)

  1. n = 196, p-value = 0.005**
  2. EF Ejection fraction, NT-proBNP N-terminal pro brain natriuretic peptide
  3. p values *< 0.05, **< 0.01, ***< 0.001 considered as significant
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us